NCT01752439

Brief Summary

The purpose of the study is to evaluate the efficacy of the transcranial direct current stimulation of the primary motor cortex (M1) in patients affected by refractory chronic migraine (coded as 1.5.1 in the international headache classification 2nd edition, 2004) and medication-overuse headache (coded as 8.1) with migraine as primary headache.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2013

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 11, 2012

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 19, 2012

Completed
1 month until next milestone

Study Start

First participant enrolled

February 1, 2013

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

December 19, 2012

Status Verified

December 1, 2012

Enrollment Period

10 months

First QC Date

December 11, 2012

Last Update Submit

December 14, 2012

Conditions

Keywords

Chronic MigraineMedication Overuse HeadacheRefractorytranscranial direct current stimulation

Outcome Measures

Primary Outcomes (2)

  • Change in headache days per months

    at 30, 60 and 90 days after the treatment

  • Change in drugs intake per months

    at 30, 60 and 90 days after treatment

Secondary Outcomes (1)

  • Change in mean pain intensity score per months

    at 30, 60 and 90 days after treatment

Study Arms (3)

Anodal transcranial direct current stimulation

EXPERIMENTAL

Anodal transcranial direct current stimulation

Device: Anodal transcranial direct current stimulation

Sham transcranial direct current stimulation

SHAM COMPARATOR

Sham transcranial direct current stimulation

Device: Sham transcranial direct current stimulation

Control group

NO INTERVENTION

Interventions

Also known as: Transcranial direct current stimulator HDCstim, Newronika s.r.l., Milan, Italy
Anodal transcranial direct current stimulation
Also known as: Transcranial direct current stimulator HDCstim, Newronika s.r.l., Milan, Italy
Sham transcranial direct current stimulation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic MIgraine or Medication Overuse Headache according to the diagnostic criteria set out in the 2nd edition of the International Classification of Headache Disorders refractory to treatment according to the Refractory Headache Special Interest Section of the American Headache Society (Schulman et al., 2008)

You may not qualify if:

  • Other primary or secondary headaches.
  • Any serious systemic or neurological disease or psychiatric disorder.
  • Pregnancy or breastfeeding
  • Previous or current use of other or similar devices for pain control
  • Heart conduction and rhythm disorders
  • Cranial surgery
  • Other pain conditions, accordingly with current guidelines

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Headache Disorders, Secondary

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Headache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

December 11, 2012

First Posted

December 19, 2012

Study Start

February 1, 2013

Primary Completion

December 1, 2013

Study Completion

March 1, 2014

Last Updated

December 19, 2012

Record last verified: 2012-12